Those of Us Who Love Working In Pharma Have a Responsibility To Patients
Last month, a friend of mine got a $2,300 bill. She had insurance, went to an in-network hospital, and the visit lasted about forty minutes. Nobody could tell her why …
Healthcare Costs Are Out of Control, and People Are Done Waiting Read More
The pharma industry has poured billions into educating physicians and patients that GLP-1’s can alter your life. Plenty of data backs this up. What pharma should be asking is. What …
Writing an Rx for a GLP-1 Drug isn’t Good Enough Read More
For decades, the pharma launch formula was relatively straightforward: hire a large sales force, buy mountains of data, flood physicians with promotion, spend heavily on conferences, hire agencies, build patient …
Rethinking Pharma Launch Costs for Better Results Read More
A cancer diagnosis creates an information problem almost immediately. Patients suddenly encounter pathology reports, biomarkers, staging, genomic testing, treatment choices, and clinical trials—all while dealing with the emotional reality of …
Outcomes4Me: Legitimate Help for Cancer Patients—or Another Way to Monetize Them? Read More
Pharma marketing has some of the smartest people in any industry, working under some of the toughest constraints. And yet we keep tripping over the same ten things. Year after …
10 Pharma Marketing Pitfalls and How to Fix Them Read More
RASONQUE may be one of the most important oncology launches in years, but its long-term commercial story is far from settled. Daraxonrasib has delivered a remarkable survival benefit in metastatic …
Did Revolution Count Their Potential Earnings Too Quickly? Read More
Americans have always disagreed about many issues in Washington. Whether it’s taxes, immigration, or healthcare. But one issue everyone could agree on was this: If a deadly contagious disease emerged. …
What America Is Doing To the CDC Read More
I think we have the conversation about healthcare all wrong in Washington. We need to understand that decreasing government spending is not the same as decreasing healthcare costs. Decreasing Medicaid …
We’re Heading Towards Medicare For All Read More